News for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)

Published at

Oct 9, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Global Asthma Treatment Market to Cross ~USD 32 Billion by 2030 | DelveInsight

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are...

NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA 0K9E.L 003520.KS VTRSV VTRS.MX VTRS VRNA VIA.DE UTHR REGN34.SA REGN.MX REGN PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MSB.AX MESO MEOBF LQDA LBPSW LBPS FRPRF DXB.AX DDDD.L AMGN.MX AMGN.BA AMGN AMG.DE ALDX 688336.SS 0R2M.L 064550.KQ

Read more →
Published at

Oct 3, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Global Inhalable Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight

The increasing incidence of respiratory conditions like asthma, COPD, and bronchitis mainly drives the growth of the inhalable drugs market. Additionally,...

ZEG.DE VTRSV VTRS.MX VTRS VIA.DE PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA MRKD.BA MRK.SN MRK.PA MRK.MX MRK LQDA LBPSW LBPS FRPRF DDDD.L AZNN.MX AZNCF AZN.L AZN 6MK.DE 0K9E.L 0A4J.L 003520.KS VRNA UTHR REGN34.SA REGN.MX REGN MSB.AX MESO MEOBF DXB.AX AMGN.MX AMGN.BA AMGN AMG.DE ALDX ABBV34.SA ABBV.MX ABBV.BA ABBV 688336.SS 4AB.DE 0R2M.L 064550.KQ

Read more →
Published at

Apr 25, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sa

The global pulmonary drugs market is projected to experience a steady CAGR between 2024 and 2030. This growth is mainly attributed to the increasing...

VRNA LBPSW LBPS FRPRF DDDD.L 003520.KS UTHR PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MSB.AX MRKD.BA MRK.SN MRK.PA MRK.MX MRK MESO MEOBF GSK.L GSK GS7.DE GRFS GRFPN.MX GRF.MC GLAXF GIKLY GIFOF GIFLF DNPUF ALDX 6MK.DE 688336.SS 4506.T 064550.KQ CAHD.BA

Read more →
Published at

Sep 25, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies - Genentech, GlaxoSmithKline, Regeneron, Sanofi,

The dynamics of the chronic obstructive pulmonary disease market are anticipated to change in the coming years owing to the improvement in the diagnosis...

LBPSW LBPS FRPRF DXB.AX DDDD.L 003520.KS VRNA UTHR MSB.AX MESO MEOBF ALDX 688336.SS 064550.KQ

Read more →
Published at

Aug 7, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Acute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly, Jasper, Jazz, Daiichi Sankyo, Amgen, AbbVie, Merck, Eli

The acute myeloid leukemia market has a promising outlook with emerging therapies. The overall dynamics of the acute myeloid leukemia market are...

STTK PGEN NXTC NOXOF NOX.AX MBRX LLY.MX LLY.DE LLY.BA LLY LILY34.SA KPTI IMU.DE IMGN GILDD.BA CYAD CCCC BPTH APTO APS.TO ALPMY ALPMF 4503N.MX 0QFK.L 0Q1G.L TKBIF TCON NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF MRKR KURA INCY INAB I1NC34.SA 688336.SS 4974.T 0TDD.L 0J9P.L

Read more →
Published at

Aug 3, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Soft Tissue Sarcoma Market to Propel by 2032, Predicts DelveInsight | Key Companies in the Market - Monopar, Jazz, Tracon, C4, Eli Lilly, Epizyme, Ipsen, GlaxoSmithKline, Salarius, Merck, Agenus, Mira

The emergence of new products in the pipeline will add to the soft tissue sarcoma market growth in the future. In addition, persistently rising cases of...

NOXOF NOX.AX TKBIF TCON MRTX MBRX LLY.MX LLY.DE LLY.BA LLY LILY34.SA INCY I1NC34.SA EPZM CCCC AGEN 688336.SS 4974.T 0Q1G.L 0J9P.L SHPMY SHPMF PHIL.MI 2607.HK

Read more →
Published at

Jun 5, 2023 5:00 PM

by prnewswire.com

mixed

mixed

Monoclonal Antibodies Clinical Trial Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain

/PRNewswire/ -- DelveInsight's 'Monoclonal Antibodies Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and...

2096.HK VCNX OMER GNRO.PA AGEN 0KBU.L BNTXN.MX BNTX 9995.HK 688336.SS 0A3M.L

Read more →
Published at

May 10, 2023 5:00 PM

by prnewswire.com

mixed

mixed

Soft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain | DelveInsight

/PRNewswire/ -- DelveInsight's 'Soft Tissue Sarcoma Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and pipeline...

TLX.AX TLPPF TKBIF TCON SHPMY SHPMF PRRUF NOXOF NOX.AX MBRX LLY.MX LLY.DE LLY.BA LLY LILY34.SA JNJ IMMP IMM.AX DJNJ3.BA DJNJ2.BA CCCC AVCTF AVCT.L 4974.T 2607.HK 0Q1G.L INCY I1NC34.SA FHTX 688336.SS 0J9P.L LIXTW LIXT

Read more →
Published at

Oct 26, 2022 7:00 PM

by globenewswire.com

mixed

mixed

Colorectal Cancer Clinical Trials Pipeline Analysis Featuring 125+ Key Companies by DelveInsight

Colorectal Cancer Pipeline constitutes 125+ key companies continuously working towards developing 150+ Colorectal Cancer treatment therapies, analyzes...

NXTC NKTR ESALY ESALF 4523.T 0UNL.L MGNK.DE BNTXN.MX BNTX 688336.SS 0A3M.L

Read more →
Published at

Jan 29, 2022 4:37 AM

by prnewswire.com

neutral

neutral

HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital

/PRNewswire/ -- HanBio Therapeutics ("HanBio"), a biotechnology company committed to researching and developing next generation transformative medicines, today...

688336.SS

Read more →